Top Palo Alto, CA Pharmaceutical Startups (49)
Drug Hunter™ is an essential subscription service for R&D-focused organizations turning molecules into medicines. Every day, drug discovery strategies, tactics, challenges and solutions are disclosed, but the knowledge is fragmented across journals, conferences, patents, databases, news, company reports, filings and endless other sources, making it challenging to find and apply. Drug Hunter’s experts keep you current by connecting the dots, distilling industry...
Evommune is a clinical-stage biotechnology company focused on discovering and developing novel therapies for immune-mediated chronic inflammatory diseases. Its mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation. The company advances a portfolio of differentiated product candidates designed to target key drivers of chronic inflammation, with the goal of addressing serious diseases where existing...
CSBio is a leading manufacturer of automated peptide synthesizers and a provider of high-quality custom and cGMP peptides for the global pharmaceutical and biotechnology community.
Earli mission is to make cancer a benign experience. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. It's called a Synthetic Biopsy. It can then localize the cancer in a PET scanner. Earli has been funded by...
ReCode Therapeutics is a biopharmaceutical company developing precision medicines for pulmonary diseases.
LighthouseAI provides state licensing software and services to companies within the pharmaceutical supply chain, to help meet requirements set by regulatory agencies. The company was born out of Pharma Solutions, a consulting and services company started in 2015 by our CEO and Founder, Sumeet Singh.
Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076's...
Adimab is the most successful antibody discovery company in the industry, with 600+ discovery campaigns and 80+ clinical programs created with more than 130 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all...
Kriya Therapeutics is a biopharmaceutical company dedicated to developing and manufacturing transformative, one-time gene therapies to address chronic diseases affecting millions of people worldwide. With operations in Research Triangle Park, North Carolina, and Silicon Valley, California, Kriya leverages an innovative platform for research, development, and manufacturing to revolutionize medicine and eliminate the burden of disease, aiming to make life-changing therapies...
Centrillion Biosciences develops and commercializes genomic and bioinformatic tools and services for personalized medicine, life sciences research, and bioinformatics. The company specializes in the advancement of synthetic biology through the creation of next-generation DNA chips and applications, including SARS-CoV-2 detection, variant tracking, and whole genome genotyping.
VIVUS is a biopharmaceutical company dedicated to the clinical development and commercialization of high-potential therapeutics. The organization focuses on transforming innovative molecules into proprietary products to address the needs of patients with serious medical conditions and life-limiting diseases, specifically specializing in obesity, sleep, and sexual health. Their mission is to improve patient quality of life and provide healthcare providers with...
We are a biopharmaceutical company focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional non-covalent drugs, including greater target selectivity, lower drug...
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems...
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than...
Pliant Therapeutics is a late-stage clinical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases and address the unmet needs of many patients. Pliant’s...
SeqMatic is a CRO Laboratory that provides superior end-to-end NGS, Multi-omics and histopathology workflow solutions including DNA, RNA, Single Cell, Epigenomics, Spatial, Histology & Bioinformatics. All work performed in Fremont, CA. Founded in 2012 by former Illumina R&D scientists. Certified by Illumina, 10x Genomics and Parse Biosciences. CLIA/CAP accredited laboratory with robust Quality Management Systems. Our work has been cited...
Claritas Rx is a digital health venture that brings clarity to the challenges of specialty biopharmaceutical products in the marketplace. In today’s highly complex specialty networks, our mission is to illuminate the patient experience beyond the clinical trial. Claritas Rx leverages a proprietary technology platform and deep manufacturer expertise to automate and integrate channel, commercial, and clinical data and help...
California Life Sciences is California’s leading advocacy and membership organization for the life sciences sector. It works with industry, government, academia, and other stakeholders to shape public policy, connect and support members, and advance innovation. It supports organizations across biotechnology, pharmaceuticals, and medical technology, helping California’s life sciences ecosystem grow and translating innovation into healthier lives. Through programs and community-building,...
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and...
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The people at Pulse Biosciences are...
